News Digest
The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to pediatric cardiometabolic health.
FDA Extends Approval for Alirocumab to Lower LDL-C in Pediatric Patients with HeFHÂ
Identifying and Treating Severe Hypoglycemia in Pediatric Patients with Diabetes
Prevention and Treatment of Pediatric Obesity: Utilizing the Spectrum of Available Tools to Optimize Treatment
Rising Cancer Incidence in Adolescents and Young AdultsÂ
Myocarditis Rates Up in Vaccinated Male Adolescents
Heart Health Month: Cardiac Dysfunction in Children with COVID-19
The Impact of Obesity on Pediatric COVID-19 Illness
Diabulimia: The World’s Most Dangerous Eating Disorder Tied to T1D
Maternal A1c Linked to Autism Risk in Children
Expert Highlights and Perspectives
A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to pediatric cardiometabolic health.
Expert Highlights & Perspectives from CMHC Pediatric Masterclass 2022 developed in collaboration with the Florida Chapter of the American Academy of Pediatrics (FCAAP)
Practical Approaches for Managing Obesity
Robert Kushner, MD
Practical Approaches for Managing Obesity
The Big Picture of Cardiometabolic Risk in the Pediatric Population - Jessica G. Woo, MHSA, PhD
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Prevention of Pediatric Obesity - Carissa M. Baker-Smith, MD, MPH
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Food Availability & Obesogenic Environments as Contributors to Overweight and Obesity in Children - Jessica G. Woo, MHSA, PhD
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Tackling Pediatric Obesity: Utilizing the Spectrum of Available Tools to Optimize Treatment - Aaron S. Kelly, Ph.D
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Panel Discussion, Audience Q & A: Lifestyle Interventions to Tackle Cardiometabolic Risk in Children and Adolescents
Panelists: Jessica G. Woo, MHSA, PhD; Carissa Baker-Smith MD; Aaron Kelly, PhD; Elaine M. Urbina, MD, MS
Hypertension in Children & Adolescents - Shani H.Cunningham, DO, M.Ed, FAAP Pediatric Dyslipidemia
Type 2 Diabetes in Children and Adolescents: Screening, Diagnosis, and Management - Jay Shubrook, DO
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Pediatric Non-Alcoholic Fatty Liver Disease: Assessment and Management - Stavra Xanthakos, MD, MS
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Target Organ Damage Related to Cardiometabolic Disease - Stephen R. Daniels, MD, PhD
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Use of Technology for Managing Obesity & Cardiometabolic Risk: Challenges, Advances & Perspectives - Eden M. Miller DO, FBOM
CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).
Panel Discussion, Audience Q & A: Comprehensive Treatment of Cardiometabolic Risk in the Pediatric Population
Moderator: Elaine M. Urbina, MD, MS
Panelists: Stephen R. Daniels, MD, PhD; Stavra Xanthakos, MD, MS; Jay Shubrook, DO; Amy L. Peterson, MD; Eden M. Miller DO, FBOM; Shani H.Cunningham, DO, M.Ed, FAAP
Resources
A collection of resources related to pediatric cardiometabolic health for both patients and provider education and connection.
- Clinical Practice Guidelines for the Evaluation and Treatment of Children and Adolescents with Obesity
- Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
- Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association
- Children and Adolescents: Standards of Care in Diabetes—2023
Collection of Slides from CMHC Masterclass: “Addressing Cardiometabolic Risk in Children and Adolescents: Challenges and Solutions”, held live on September 2022 in collaboration with the Florida Chapter of the American Academy of Pediatrics (FCAAP)
- 01_Overview of Cardiometabolic Burden in Pediatrics - Elaine M. Urbina MD.pdf
- 02_The Big Picture of Obesity and Metabolic Syndrome in the Pediatric Population - Jessica G. Woo, PhD.pdf
- 03_Prevention of Pediatric Obesity - Carissa M. Baker-Smith, MD.pdf
- 04_Food Availability and Obesogenic Environments as Contributors to Overweight and Obesity in Childhood - Jessica G. Woo, PhD.pdf
- 05_Tacking Pediatric Obesity - Utilizing the Spectrum of Available Tools to Optimize Treatment - Aaron S. Kelly, PhD.pdf
- 06_The Pressure is Rising - Hypertension in Children and Adolescents - Shani Cunningham, DO.pdf
- 07_Pediatric Dyslipidemia - Amy L. Peterson, MD.pdf
- 08_Type 2 Diabetes in Children and Adolescents - Screening, Diagnosis, and Management - Jay H. Shubrook, DO.pdf
- 09_Pediatric Non-alcoholic Fatty Liver Disease - Assessment and Management - Stavra Xanthakos, MD.pdf
- 10_Target Organ Damage Related to Cardiometabolic Disease in Children and Adolescents - Stephen R. Daniels, MD, PhD.pdf
- 11_Use of Technology for Managing Obesity & Cardiometabolic Risk - Challenges, Advances, and Perspectives - Eden Miller DO.pdf
Drug Pipeline
Key emerging drugs for the management of select and relevant pediatric cardiometabolic health conditions that are being studied in various stages of clinical trials, or that were recently approved by the U.S. Food and Drug Administration for therapeutic use.
HeFH = heterozygous familial hypercholesterolemia; HoFH = homozygous familial hypercholesterolemia; PCSK9 = Proprotein convertase subtilisin/kexin type 9
